logo
  • genedrive.com
  • About us
    • Company profile
    • Board of directors
    • Advisors
  • Our product
  • News & Events
    • Press releases
    • Events
    • Media
  • Careers
    • Careers
    • Applicants Privacy Notice
  • Investor relations
    • AIM Rule 26
    • Investor relations
    • Shareholders
    • Share price information
    • Regulatory news
    • Reports & presentations
    • Constitutional documents
    • Investor news
    • Corporate governance
    • Investor contacts
    • Company information

Investor news

Home > Investor relations > Investor news

Thursday May 23, 2019

Genedrive making commercial progress

Friday March 29, 2019

Peel Hunt resumes coverage of Genedrive with a ‘buy’ rating and 60p price target after recent results

Thursday March 28, 2019

Genedrive optimistic about some near-term progress on its Genedrive HCV ID registrations

Tuesday January 15, 2019

Genedrive receives second order from US Department of Defense

Thursday November 29, 2018

US giant AbbVie to fund trial of genedrive's hep C test

Thursday November 22, 2018

Genedrive 'well placed' to grow the business after £6mln equity raise

Friday November 16, 2018

Genedrive welcomes BGF as a cornerstone investor as it proposes to raise £6mln

Wednesday August 08, 2018

Genedrive partners with FIND to evaluate Hepatitis C diagnostic kit in Cameroon and Georgia

Friday July 13, 2018

genedrive shares push higher as the rapid diagnostics specialist gears up for important year

Thursday June 21, 2018

Genedrive on track to commercialise its diagnostic products

Latest reports

share price graph

01 April 2019

Interim Presentation 31 December 2018

View all reports >

Share price

Share price details >

  • Privacy
  • Terms of use
  • Site map
  • Contact us

© 2017-19 genedrive plc

genedrive plcThis site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.

Don't show this againclose